Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 3,228.54 | 1,454.84 | 2,797.18¢ | 10.5 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,431.59 | 1,690.74 | 2,846.67¢ | 10.3 | 5.8 | +2% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
Contracting | 06-Dec-2007 | Washington Post |
United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
Currency | US Dollars |
Share Price | $ 292.65 |
Change Today | $ -1.63 |
% Change | -0.55 % |
52 Week High | $410.00 |
52 Week Low | $274.70 |
Volume | 909,297 |
Shares Issued | 43.56m |
Market Cap | $12,749m |
RiskGrade | 132 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 15 |
Time | Volume / Share Price |
15:59 | 100 @ $292.82 |
15:59 | 100 @ $292.85 |
15:59 | 100 @ $292.84 |
15:59 | 100 @ $293.05 |
15:59 | 100 @ $292.60 |
You are here: research